A Post-hoc Analysis of CheckMate 9ER Data and Study Conclusions

Video

A brief overview of post-hoc data from the CheckMate 9ER trial examining baseline characteristics and time to subsequent therapy in patients who received at least two years of nivolumab treatment, followed by study conclusions.

Related Videos